You have 9 free searches left this month | for more free features.

City

Adelaide (1)

Beijing (1)

Nanjing (1)

Tianjin (1)

Zhengzhou (1)

Condition

Paroxysmal Nocturnal Hemoglobinuria (2)

Systemic Lupus Erythematosus (1)

Overall Status

Not yet recruiting (2)

Active, not recruiting (1)

Sign in for free

Phase

phase 2 (2)

phase 1 (1)

Sponsor

Kira Pharmacenticals (US), LLC. (3)

Collaborator

Intervention

kp104 (3)

placebo (1)

Study Documents

Intervention Type

drug (3)

Funder Type

Industry (3)

Study Type

Interventional (3)

kp104

Showing 1 - 3 of 3

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Systemic Lupus Erythematosus Trial (KP104)

Not yet recruiting

Systemic Lupus Erythematosus

KP104

(no location specified)

Aug 15, 2022

Paroxysmal Nocturnal Hemoglobinuria Trial in Adelaide (KP104, Placebo)

Active, not recruiting

Paroxysmal Nocturnal Hemoglobinuria

KP104
Placebo

Adelaide, Australia

CMAX Clinical Research

Aug 4, 2022

Paroxysmal Nocturnal Hemoglobinuria Trial in China (KP104)

Not yet recruiting

Paroxysmal Nocturnal Hemoglobinuria

KP104

Beijing, China
+3 more

Jul 25, 2022